Description
GLP-2 TIRZ is an innovative research peptide that synergizes the effects of GLP-2 (Glucagon-Like Peptide-2)—known for promoting intestinal growth and repair—with Tirzepatide, a dual GIP and GLP-1 receptor agonist recognized for its metabolic and anti-obesity potential.
This advanced compound is being studied for its potential to:
-
Support gastrointestinal healing and mucosal regeneration
-
Improve nutrient absorption and gut barrier function
-
Enhance insulin sensitivity and glucose control
-
Reduce appetite and promote weight loss
-
Address metabolic and digestive disorders in combination therapy research
GLP-2 TIRZ is strictly intended for research purposes only and is not approved for human or veterinary use. It represents a promising area of study in gastrointestinal health, diabetes, and obesity-related conditions.
There are no reviews yet.